Effect of coadministration of enriched Korean Red Ginseng (Panax ginseng) and American ginseng (Panax quinquefolius L) on cardiometabolic outcomes in type-2 diabetes: A randomized controlled trial

Author:

Jovanovski Elena,Smircic-Duvnjak Lea,Komishon Allison,Au-Yeung Fei (Rodney),Sievenpiper John L.,Zurbau Andreea,Jenkins Alexandra L.,Sung Mi-Kyung,Josse Robert,Li Dandan,Vuksan Vladimir

Funder

Canadian Diabetes Association

BTGin Corp.

Diabetes Alternative Research

Healthcare Foundation

PSI Graham Farquharson Knowledge Translation Fellowship

CIHR

INMD

CNS

Banting & Best Diabetes Centre Sun Life Financial New Investigator Award

Canadian Institutes of health Research

Diabetes Canada

PSI Foundation

Banting and Best Diabetes Centre

Canadian Nutrition Society

American Society for Nutrition

Calorie Control Council

INC International Nut and Dried Fruit Council Foundation

National Dried Fruit Trade Association

University of Toronto

Dr. Pepper Snapple Group

Dairy Farmers of Canada

Nutrition Foundation of Italy

C3 Collaborating for Health

Sprim Brasil

WhiteWave Foods

Rippe Lifestyle

mdBriefcase

Alberta Milk

FoodMinds LLC

Memac Ogilvy & Mather LLC

PepsiCo

The Ginger Network LLC

International Sweeteners Association

Pulse Canada

GI Foundation

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Biochemistry, Genetics and Molecular Biology (miscellaneous),Biotechnology

Reference39 articles.

1. Impact of hypertension versus diabetes on cardiovascular and all-cause mortality in Iranian older adults: results of 14 Years of follow-up;Zafari;Sci Rep,2017

2. Use of complementary therapies in cardiovascular disease;Prasad;Am J Cardiol,2013

3. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety;Vuksan;Nutr Metab Cardiovasc Dis,2008

4. Efficacy and safety of American ginseng (panax quinquefolius L) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, crossover clinical trial;Vuksan;Eur J Nutr,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3